[6-K] Alvotech Current Report (Foreign Issuer)

Rhea-AI Filing Summary

Alvotech filed a Form 6-K that incorporates by reference three exhibits tied to its public filings: unaudited condensed consolidated interim financial statements for the six months ended June 30, 2025 and June 30, 2024 (Exhibit 99.1), Management's Discussion and Analysis (Exhibit 99.2) and an earnings release for the six months ended June 30, 2025 (Exhibit 99.3).

The company also announced a business update conference call and live webcast on Thursday, August 14 at 8:00 am ET, with a replay available on its website for 90 days. The report includes a standard cautionary note that forward-looking statements involve risks and may differ materially from actual results.

Positive

• Exhibit 99.1: Inclusion of unaudited condensed consolidated interim financial statements for the six months ended June 30, 2025 and June 30, 2024.
• Exhibit 99.2: Inclusion of Management's Discussion and Analysis, providing management narrative on financial condition and results.
• Scheduled webcast: Business update conference call and live webcast on August 14 with replay available for 90 days, offering direct management access.

Negative

• Exhibit 99.3 furnished, not filed: The earnings release is furnished and therefore not subject to Section 18 liability and not incorporated by reference, limiting certain legal protections.
• No financial detail in the 6-K text: The filing references interim financials and MD&A but does not include numerical results in-line; investors must open exhibits for material metrics.

Insights

Financial Analyst

TL;DR The 6-K provides the company's unaudited interim financials, MD&A and an earnings release; investors must review the exhibits for material detail.

The filing formally incorporates interim financial statements for the six-month periods ending June 30, 2025 and 2024 and includes MD&A, which together should disclose operating results, cash flow and reserve movements for the period. Absent the exhibit content in the 6-K text, the filing itself is a routine conduit; market impact will depend on the underlying numbers and commentary in Exhibits 99.1–99.3. The scheduled webcast offers a direct channel for management commentary.

Corporate Governance Expert

TL;DR The disclosure follows standard SEC practice: exhibits incorporated by reference and an earnings release furnished rather than filed.

From a governance and disclosure perspective, the company has met procedural requirements by incorporating interim statements and MD&A into its registration statements and furnishing an earnings release. Notably, Exhibit 99.3 is explicitly furnished and therefore not subject to Section 18 liability or incorporation by reference, which is an important distinction for legal exposure and investor recourse. The forward-looking statement disclaimer is standard.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the Month of August 2025

Commission File Number: 001-41421

Alvotech

(Translation of registrant’s name into English)

9, Rue de Bitbourg,

L-1273 Luxembourg,

Grand Duchy of Luxembourg

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

☒  Form 20-F    ☐  Form 40-F

INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K

Incorporation by Reference

Certain exhibits to this Report on Form 6-K (this “Report”) of Alvotech (the “Company”), including Exhibits 99.1 and 99.2, attached hereto, shall be deemed to be incorporated by reference into the Company’s registration statements on Forms F-3 (File Nos. 333-266136, 333-273262, and 333-275111 and 333-281684) and the Company’s registration statement on Form S-8 (File No. 333-266881) and to be a part thereof from the date on which this Report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

Exhibit 99.3 to this Report is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.

Business Update Conference Call

The Company will conduct a business update conference call and live webcast on Thursday, August 14, at 8:00 am ET (12:00 pm GMT). A live webcast of the call and the presentation will be available on the Company’s website, where you will also be able to find a replay of the webcast, following the call for 90 days.

Cautionary note on forward-looking statements

This Report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “may,” “will,” “expect,” “plan,” “anticipate,” “estimate,” “intend” and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. These forward-looking statements are based on the Company’s expectations and assumptions as of the date of this Report. Each of these forward-looking statements involves risks and uncertainties. Actual results may differ materially from those expressed or implied by these forward-looking statements. For a discussion of risk factors that may cause the Company’s actual results to differ from those expressed or implied in the forward-looking statements in this Report, you should refer to the Company’s filings with the U.S. Securities and Exchange Commission, including the “Risk Factors” sections contained therein. Except as required by law, the Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. You should, therefore, not rely on these forward-looking statements as representing the Company’s views as of any date subsequent to the date of this Report.

EXHIBIT INDEX

Exhibit No.						Description
99.1						Unaudited Condensed Consolidated Interim Financial Statements as of 30 June 2025 and for the six months ended June 30, 2025 and June 30, 2024.
99.2						Management’s Discussion and Analysis of Financial Condition and Results of Operations.
99.3						Earnings Release for the six months ended June 30, 2025.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

ALVOTECH

Date:

August 13, 2025

By:

/s/ Tanya Zharov

Name:

Tanya Zharov

Title:

General Counsel

FAQ

What did Alvotech (ALVO) disclose in this Form 6-K?

The company incorporated by reference unaudited interim financial statements for the six months ended June 30, 2025 and 2024 (Exhibit 99.1), the MD&A (Exhibit 99.2), and furnished an earnings release (Exhibit 99.3).

When is Alvotech's business update webcast for ALVO?

Alvotech will hold a business update conference call and live webcast on Thursday, August 14 at 8:00 am ET, with a replay available on the company website for 90 days.

Is the earnings release in the 6-K filed or furnished for ALVO?

Exhibit 99.3, the earnings release, is explicitly furnished and is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference.

Does the 6-K include forward-looking statements for ALVO?

Yes; the report contains a cautionary note that forward-looking statements involve risks and actual results may differ materially from those statements.

Where can investors find the exhibits referenced in the 6-K?

The Form 6-K references Exhibits 99.1, 99.2 and 99.3 which are attached to the report and are incorporated by reference or furnished as stated; investors should review those exhibits for detailed financials and commentary.